GB2448440B - A method for preventing reduced feed intake in animals and treatment of disease conditions - Google Patents

A method for preventing reduced feed intake in animals and treatment of disease conditions

Info

Publication number
GB2448440B
GB2448440B GB0812494A GB0812494A GB2448440B GB 2448440 B GB2448440 B GB 2448440B GB 0812494 A GB0812494 A GB 0812494A GB 0812494 A GB0812494 A GB 0812494A GB 2448440 B GB2448440 B GB 2448440B
Authority
GB
United Kingdom
Prior art keywords
animals
treatment
feed intake
disease conditions
reduced feed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB0812494A
Other versions
GB0812494D0 (en
GB2448440A (en
Inventor
James Baber Rowe
Christopher William Rowe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HANCROFT Pty Ltd
Original Assignee
HANCROFT Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2005907069A external-priority patent/AU2005907069A0/en
Application filed by HANCROFT Pty Ltd filed Critical HANCROFT Pty Ltd
Publication of GB0812494D0 publication Critical patent/GB0812494D0/en
Publication of GB2448440A publication Critical patent/GB2448440A/en
Application granted granted Critical
Publication of GB2448440B publication Critical patent/GB2448440B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GB0812494A 2005-12-15 2006-12-15 A method for preventing reduced feed intake in animals and treatment of disease conditions Expired - Fee Related GB2448440B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2005907069A AU2005907069A0 (en) 2005-12-15 A method for preventing reduced feed intake in animals and treatment of disease conditions
PCT/AU2006/001901 WO2007068055A1 (en) 2005-12-15 2006-12-15 A method for preventing reduced feed intake in animals and treatment of disease conditions

Publications (3)

Publication Number Publication Date
GB0812494D0 GB0812494D0 (en) 2008-08-13
GB2448440A GB2448440A (en) 2008-10-15
GB2448440B true GB2448440B (en) 2011-05-04

Family

ID=38162484

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0812494A Expired - Fee Related GB2448440B (en) 2005-12-15 2006-12-15 A method for preventing reduced feed intake in animals and treatment of disease conditions

Country Status (5)

Country Link
US (1) US8173120B2 (en)
AU (1) AU2006324390B2 (en)
GB (1) GB2448440B (en)
NZ (1) NZ569627A (en)
WO (1) WO2007068055A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101245362B (en) * 2008-03-24 2011-05-11 南京工业大学 Method for producing polypeptide enramycin with zymotechnics
CN104434777B (en) * 2014-12-29 2015-10-21 江西兴鼎科技有限公司 A kind of method improving enramycin premix finished product stability
US20190269740A1 (en) * 2016-10-26 2019-09-05 Nutech Ventures Use of probiotic bacterial strains and cell extracts to inhibit acidosis and liver abscesses in cattle
US10947576B2 (en) * 2017-07-25 2021-03-16 Arizona Board Of Regents On Behalf Of Arizona State University Rapid antibiotic susceptibility testing by tracking sub-micron scale motion of single bacterial cells
CN108059657A (en) * 2018-01-18 2018-05-22 山西新源华康化工股份有限公司 A kind of production technology for preventing enramycin product from degrading
CN108157355A (en) * 2018-03-30 2018-06-15 潍坊学院 Cut Carnation Flower liquid for immersing in bottle
CN108864256B (en) * 2018-07-17 2022-02-01 浙江工商大学 Method for separating and purifying enramycin A and enramycin B
CN109917051A (en) * 2019-04-22 2019-06-21 湖北出入境检验检疫局检验检疫技术中心 Method that is a kind of while detecting multiple polypeptides class drug in egg

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0335704B1 (en) * 1988-03-30 1993-09-29 James Baber Rowe Treatment of equine livestock
WO1996020709A1 (en) * 1994-12-29 1996-07-11 James Baber Rowe Prevention of adverse behaviour, diarrhoea, skin disorders and infections of the hind gut associated with acidic conditions in humans and animals
WO1999020305A1 (en) * 1997-10-17 1999-04-29 Fort Dodge Australia Pty. Limited Veterinary vaccines
WO2006100263A2 (en) * 2005-03-23 2006-09-28 Klat Pharma Animal Health Gmbh Use of amides of sulfadimidine for the treatment of intestinal diseases in veterinary science

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO758297A0 (en) * 1997-06-27 1997-07-24 Rowe, James Baber Control of acidic gut syndrome

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0335704B1 (en) * 1988-03-30 1993-09-29 James Baber Rowe Treatment of equine livestock
WO1996020709A1 (en) * 1994-12-29 1996-07-11 James Baber Rowe Prevention of adverse behaviour, diarrhoea, skin disorders and infections of the hind gut associated with acidic conditions in humans and animals
WO1999020305A1 (en) * 1997-10-17 1999-04-29 Fort Dodge Australia Pty. Limited Veterinary vaccines
WO2006100263A2 (en) * 2005-03-23 2006-09-28 Klat Pharma Animal Health Gmbh Use of amides of sulfadimidine for the treatment of intestinal diseases in veterinary science

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
Bull Off Int Epizoot., Vol. 67, 1967, B C Jansen, "The prevention of enterotoxaemia (pulpy kidney disease) by vaccination.", pages 1539-67. *
Equine Veterinary Journal, Vol. 27, 1995, M R Slater, et al., "Descriptive epidemiological study of equine laminitis", pages 364-367. *
Equine Veterinary Journal, Vol. 30, 1998, K G Johnson, et al., "Behavioural changes in stabled horses given nontherapeutic levels of virginiamycin", pages 139-143. *
Equine Veterinary Journal, Vol. 36, 2004, E J Hedderson, et al., "Prospects for vaccination against equine grass sickness", pages 186-191. *
In Practice, Vol. 19, 1997, E Milne, "Grass sickness: an update", pages 128-133. *
J Anim Sci., Vol. 76, 1998, F N Owens, et al., "Acidosis in cattle: a review", pages 275-86. *
Vlaams Diergeneeskundig Tijdschrift, Vol. 52, 1983, M Sterne, "Clostridial Infections", pages 414-425. *

Also Published As

Publication number Publication date
GB0812494D0 (en) 2008-08-13
NZ569627A (en) 2012-01-12
US8173120B2 (en) 2012-05-08
WO2007068055A1 (en) 2007-06-21
AU2006324390A1 (en) 2007-06-21
AU2006324390B2 (en) 2013-08-01
US20090053188A1 (en) 2009-02-26
GB2448440A (en) 2008-10-15

Similar Documents

Publication Publication Date Title
GB2448440B (en) A method for preventing reduced feed intake in animals and treatment of disease conditions
EP1880733A4 (en) Method for increasing longevity of a human being and animals
IL249236A0 (en) Materials and methods for respiratory disease control in canines
EP1732381A4 (en) Animal feeding device and method
EP1862081A4 (en) Feed composition and method of breeding animal
EP1737293A4 (en) Method and system for automatically feeding animals
PT1711070E (en) Nutritional composiition for improving skin condition and preventing skin diseases
EP1755598A4 (en) Methods for treating arthritic conditions in dogs
EP1705986A4 (en) Method and system for aquaculture production
GB0814833D0 (en) Method and device for treating sleep apnea
ZA200809402B (en) Apparatus and method to remove animal waste from litter
EP1963520A4 (en) Method for monitoring and promoting the nutrition and well-being of an animal and/or a human being as well as the productivity of animals
PL380825A1 (en) Alfa-aminoamid derivatives useful in treating lower urinary tract diseases
EP1879446A4 (en) Animal toileting system and method
TWI350182B (en) Pharmaceutical compositions and method for treating inflammation in cattle and other animals
EP1906975A4 (en) Method for treating sickle cell disease and sickle cell disease sequelae
HK1117993A1 (en) Method for treating and preventing scuticociliatosis in fishes
EP1736165A4 (en) Antidiarrheal agent for livestock and poultry
EP2046114A4 (en) Step-down suckling method for minimizing weaning stress in newborn calf
ZA200808076B (en) Methods for preventing and treating amyloidogenic diseases
GB0403600D0 (en) Methods and reagents for treating disease
AU2005907069A0 (en) A method for preventing reduced feed intake in animals and treatment of disease conditions
GB2439909B (en) Animal and livestock feedstuff
IL195960A0 (en) Means and method for enhancing a human sexual activity
AU2003265809A1 (en) Method to treat laminitis and reduce dietary intake for horses

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20151215